Product Information
CELECOXIB 400 MG CAPSULE is a generic product labeled by ScieGen Pharmaceuticals, Inc., priced at $0.2480 per EA under NDC 50228015960. Its NADAC has been published 226 times since Jun 8, 2022.
FDA first approved this application on Dec 3, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
400 mg/1
Manufacturer
ScieGen Pharmaceuticals, Inc.NDC
50228015960
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CELECOXIBApproval Type
Generic (ANDA)
FDA Application
ANDA205129FDA Approved
12/3/2020
TE Code
AB
On Market Since
12/3/2020
Pharmacological Classes
Price Statistics
The NADAC for CELECOXIB 400 MG CAPSULE has been published 226 times since Jun 8, 2022, and over the history we have for it it has declined 28.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2480 per EA |
|---|---|
| All-time high | $0.5369 (Jul 13, 2022) |
| All-time low | $0.2055 (Jul 22, 2026) |
| 52-week high | $0.3409 |
| 52-week low | $0.2055 |
| Median price | $0.3423 |
| Average price | $0.3464 |
| Largest weekly change | +54.7% (Jun 22, 2022) |
| Weeks tracked | 226 |
| Tracking since | Jun 8, 2022 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 10% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ScieGen Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Celecoxib market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CELECOXIB 400 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for CELECOXIB 400 MG CAPSULE, manufactured by ScieGen Pharmaceuticals, Inc., is $0.2480 per EA (NDC 50228015960), effective Sep 30, 2026.
How has the price of CELECOXIB 400 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for CELECOXIB 400 MG CAPSULE has declined 28.5%. It has been tracked across 226 weekly CMS publications since Jun 8, 2022.
What are the highest and lowest recorded NADAC prices for CELECOXIB 400 MG CAPSULE?
Since Jun 8, 2022, the NADAC for CELECOXIB 400 MG CAPSULE has ranged from a low of $0.2055 (Jul 22, 2026) to a high of $0.5369 (Jul 13, 2022), with a median of $0.3423 per EA.
Are there cheaper alternatives to CELECOXIB 400 MG CAPSULE?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, CELECOXIB 400 MG CAPSULE, is $0.2228 per EA — about 10% below CELECOXIB 400 MG CAPSULE.
Who manufactures CELECOXIB 400 MG CAPSULE?
CELECOXIB 400 MG CAPSULE (NDC 50228015960) is labeled by ScieGen Pharmaceuticals, Inc., and CMS classifies it as a generic product.